Patent ID: 7081473

Claim:
A method to treat obesity resulting from GIP function in a mammal comprising administering to the subject an effective amount of a compound represented by the following general formula (I): (wherein R 1 represents hydrogen, a halogen atom, a nitro group or a cyano group, R 2 represents hydrogen or a halogen atom or may, together with R 3 , form an optionally substituted benzene ring or an optionally substituted pyrrole ring, R 3 represents hydrogen or a methoxy group or may, together with R 2 , form an optionally substituted benzene ring or an optionally substituted pyrrole ring or may, together with R 4 , form an optionally substituted benzene ring or an optionally substituted pyrrole ring, and A represents a nitrogen atom or C—R 4 whereupon R 4 represents hydrogen, an optionally substituted C1 to C6 alkyl group, —OR 7 , —NR 8 R 9 , —NHCO—R 10 or —SO 2 —R 11 or may, together with R 3 , form an optionally substituted benzene ring or an optionally substituted pyrrole ring, R 7 , R 8 and R 9 independently represent hydrogen or an optionally substituted C1 to C6 alkyl group, R 10 represents a C1 to C6 alkyl group, a C3 to C6 cycloalkyl group, an optionally substituted furyl group, an optionally substituted thienyl group, an optionally substituted benzyl group, an optionally substituted benzyloxymethyl group, an optionally substituted phenylvinyl group or an optionally substituted phenoxymethyl group, and R 11 represents an optionally substituted morpholyl group, an optionally substituted cyclopentylamino group, an optionally substituted piperidinyl group or a diethylamino group) or a pharmaceutically acceptable salt thereof.